Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studies | Zendy

Xiaoli Wu | Zendy; Daofu Zhang | Zendy; Yuexiao Yu | Zendy; Lianqing Lou | Zendy; Xiaofei Li | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Proton pump inhibitor use and mortality in patients with cirrhosis: a meta-analysis of cohort studies

Author(s) -

Xiaoli Wu,

Daofu Zhang,

Yuexiao Yu,

Lianqing Lou,

Xiaofei Li

Publication year - 2020

Publication title -

bioscience reports

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.938

H-Index - 77

eISSN - 1573-4935

pISSN - 0144-8463

DOI - 10.1042/bsr20193890

Subject(s) - medicine , meta analysis , cirrhosis , relative risk , proton pump inhibitor , subgroup analysis , prospective cohort study , cohort study , cohort , randomized controlled trial , adverse effect , confidence interval , publication bias , retrospective cohort study , gastroenterology

Proton pump inhibitor (PPI) is commonly used in patients with cirrhosis. However, some studies demonstrated that PPI use was associated with adverse outcome in patients with cirrhosis. We aimed to perform a meta-analysis of cohort studies to evaluate the association between PPI use and mortality in cirrhotic patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research